Shashank Chaturvedi

Shashank Chaturvedi

Auto-generated profile, based on publicly available information

Shashank Chaturvedi

Institute of Pharmaceutical Research, GLA University, NH-2 Mathura Delhi Road, P.O.-Chaumuhan, Mathura281406 (U.P.), India

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 October 2020 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
SCShashank Chaturvedi
Shashank Chaturvedi
AGAnuj Garg
Anuj Garg
AVAnurag Verma
Anurag Verma

9 August 2020 in Advanced Pharmaceutical Bulletin
Verified
Journal Article
Closed access
PDF file
SCShashank Chaturvedi
Shashank Chaturvedi
AVAnurag Verma
Anurag Verma
VSVikas Anand Saharan
Vikas Anand Saharan
In the treatment of cancer, chemotherapy plays an important role though the efficacy of anticancer drug administered orally is limited, due to their poor solubility in physiological medium, inability to cross biological membrane, high Para-glycoprotein (P-gp) mediated drug efflux, and pre-systemic metabolism. These all factors cumulatively reduce drug exposure at the target site leading to multidrug resistance (MDR). Lipid based carriers systems has been explored to overcome solubility and permeability related issues of anti-cancer drugs. The lipid based formulations have also been reported to circumvent the effect of P-gp and CYP3A4. Further long chain triglycerides (LCT) has shown their ability to access Lymphatic route over Medium Chain Triglycerides, as the former has been extensively used for targeting anti-cancer drugs at proliferating cells through lymphatic route. Therefore this review tries to reflect the usefulness of lipid based drug carriers systems (viz. liposome, solid lipid nanoparticle, nano-lipid carriers, self-emulsifying, lipidic pro-drugs) in targeting lymphatic system and overcoming issues related to solubility and permeability of anti-cancer drugs. Moreover, we have also tried to reflect how critically lipid based carriers are important in maximizing therapeutic safety and efficacy of anti-cancer drugs.

4 January 2023 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
SCShashank Chaturvedi
Shashank Chaturvedi
AGAnuj Garg
Anuj Garg

28 December 2022 in Revista Brasileira de Farmacognosia
Verified
Journal Article
Closed access
PDF file
SCShashank Chaturvedi
Shashank Chaturvedi
SAShruti Agrawal
Shruti Agrawal
AGAnuj Garg
Anuj Garg
VRVaibhav Rastogi
Vaibhav Rastogi

4 August 2022 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
SCShashank Chaturvedi
Shashank Chaturvedi
AGAnuj Garg
Anuj Garg